Charles Moore
Stock Analyst at Robert W. Baird
(2.52)
# 2,877
Out of 4,455 analysts
7
Total ratings
57.1%
Success rate
9.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Moore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintained: Buy | $32 → $34 | $25.57 | +32.97% | 2 | Apr 7, 2026 | |
| CTNM Contineum Therapeutics | Maintained: Buy | $14 → $20 | $14.19 | +40.94% | 2 | Mar 6, 2026 | |
| DRUG Bright Minds Biosciences | Maintained: Buy | $142 → $126 | $65.79 | +91.52% | 3 | Feb 13, 2026 |
Denali Therapeutics
Apr 7, 2026
Maintained: Buy
Price Target: $32 → $34
Current: $25.57
Upside: +32.97%
Contineum Therapeutics
Mar 6, 2026
Maintained: Buy
Price Target: $14 → $20
Current: $14.19
Upside: +40.94%
Bright Minds Biosciences
Feb 13, 2026
Maintained: Buy
Price Target: $142 → $126
Current: $65.79
Upside: +91.52%